Skip to main content
Pharmanutra logo

Pharmanutra — Investor Relations & Filings

Ticker · PHN ISIN · IT0005274094 LEI · 815600F8217BC7733697 XMIL Manufacturing
Open in API
Filings indexed 601 across all filing types
Latest filing 2017-07-14 Share Issue/Capital Cha…
Country IT Italy
Listing XMIL PHN

About Pharmanutra

http://www.pharmanutra.it

PharmaNutra is a company operating in the pharmaceutical and nutraceutical sectors, focused on the development and distribution of nutritional supplements and medical devices. Grounded in scientific research, the company creates innovative solutions for health and wellness. Its core activities center on addressing nutritional deficiencies, particularly iron, through proprietary functional ingredients and technologies. The product portfolio also extends to supporting muscle and joint health, sports nutrition, and applications across various therapeutic areas, including gynecology, orthopedics, hematology, and gastroenterology. The company emphasizes the development of effective and safe products supported by clinical evidence.

Recent filings

Filing Released Lang Actions
AMMISSIONE ALLE NEGOZIAZIONI DELLE AZIONI ORDINARIE E DEI WARRANT DI PHARMANUTRA S.P.A. SUL MERCATO AIM ITALIA
Share Issue/Capital Change Classification · 1% confidence The document is an official communication from PharmaNutra S.p.A. to the market, identified by the header 'Informazione Regolamentata' (Regulated Information) and the subject line: 'AMMISSIONE ALLE NEGOZIAZIONI DELLE AZIONI ORDINARIE E DEI WARRANT DI PHARMANUTRA S.P.A. SUL MERCATO AIM ITALIA' (Admission to Trading of Ordinary Shares and Warrants of PharmaNutra S.p.A. on the AIM Italia Market). This announcement details the successful listing/admission of shares and warrants to trade on the AIM Italia market, effective July 18, 2017. This type of announcement, concerning the structure of capital and listing status, falls under Capital/Financing Update (CAP) or potentially Regulatory Filings (RNS). Since it specifically details the admission to trading following a process (IPO Challenger 1 SPAC), it is fundamentally a capital structure/financing event announcement. Given the options, 'Capital/Financing Update' (CAP) is the most precise fit for an admission to trading announcement, as it relates directly to the company's capital structure being made public/tradable.
2017-07-14 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.